Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Antipsychotic Augmentation With L-Dopa [Phase 2]
Phase 2 trial assessing augmentation of an antipsychotic with L-Dopa in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia [Phase 4]
A Phase 4 safety and effectiveness study of paliperidone palmitate in Chinese patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine [Phase 4]
Phase 4 clinical trial comparing olanzapine alone to low-dose olanzapine plus trifluoperazine for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: The Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot Study [Phase 1]
Phase 1 pilot trial evaluating the effect of nitric oxide on spatial working memory in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia [NA]
A clinical trial update announcing completion of a study evaluating repetitive transcranial magnetic stimulation as an add-on treatment for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective [Phase 1]
Clinical trial update indicating completion of a Phase 1 multiple ascending dose study evaluating safety, tolerability, and pharmacokinetics…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Efficacy of Pimozide Augmentation for Clozapine Partial Response [Phase 2]
Phase 2 trial evaluating whether adding pimozide to clozapine improves outcomes in schizophrenia patients with partial response. The results…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Efficacy Study of GAÏA Program Cognitive Remediation of Facial Affects Processing in Schizophrenia [NA]
A completed efficacy study of the GAÏA cognitive remediation program for facial affect processing in schizophrenia. The snippet does not pro…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia [Phase 4]
A Phase 4 randomized, double-blind trial comparing amisulpride alone to a low-dose amisulpride plus sulpiride regimen in schizophrenia was t…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. [Phase 4]
This Phase 4 trial update analyzes the significance of deviations from the 12-hour serum clozapine monitoring schedule in patients with schi…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Oxytocin as Adjunctive Therapy for Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating oxytocin as adjunctive therapy for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia [NA]
Completed clinical trial evaluating transcranial current stimulation for auditory hallucinations in schizophrenia; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Effects of Cognitive Remediation Therapy on Schizophrenia Patients Through Functional Magnetic Resonance Imaging [NA]
A completed trial evaluating cognitive remediation therapy in schizophrenia, using functional MRI to assess brain changes and cognitive outc…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Effectiveness of Adherence Therapy for Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial from The Hong Kong Polytechnic University evaluating the effectiveness of adherence therapy for schizophre…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Guideline vs Usual Treatment in Schizophrenic Adolescents [NA]
Completed clinical trial comparing guideline-based treatment to usual care in adolescents with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia [NA]
The clinical trial testing whether a Nintendo Wii-based intervention can improve negative symptoms and quality of life in schizophrenia has …
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: The Effect of Plasma Osmolality on Brain Glutamate [Phase 1]
Phase 1 trial investigating the effect of plasma osmolality on brain glutamate levels in schizophrenia; study completed.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults [Phase 2]
A Phase 2 clinical trial evaluating a cognitive adaptive e-treatment for adults with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Sodium Oxybate in Schizophrenia With Insomnia [Phase 2]
Phase 2 clinical trial update of sodium oxybate in schizophrenia with insomnia; the study has completed and results were posted in February …
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. [Phase 3]
A Phase 3 trial evaluating the safety and tolerability of aripiprazole in adolescents with schizophrenia and in children/adolescents with Bi…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Psychosis: Early Detection, Intervention and Prevention [NA]
Clinical trial update from MaineHealth reports completion and posted results for a study on psychosis focusing on early detection, intervent…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism [Phase 1]
Phase 1 Yale trial examined the effects of NMDA receptor antagonism in schizophrenia, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Nicotinic Receptors and Schizophrenia [Phase 1]
Phase 1 trial evaluating nicotinic receptor targets in schizophrenia. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia [Phase 1]
Phase 1 PET imaging study to assess receptor occupancy of brexpiprazole in adults with schizophrenia; completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Reducing Internalized Stigma in People With Serious Mental Illness [Phase 2]
Phase 2 trial update evaluating an intervention to reduce internalized stigma in people with serious mental illness, including schizophrenia…